Status:
COMPLETED
NoL, HR and MABP Responses to Tracheal Intubation Performed With MAC Blade Versus Glidescope
Lead Sponsor:
Ciusss de L'Est de l'Île de Montréal
Collaborating Sponsors:
Verathon
Canadian Hospital Specialties Ltd
Conditions:
Intubation
Nociceptive Pain
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Prospective, randomized and controlled who will be conducted in Maisonneuve-Rosemont hospital and whose objectives are: * To observe if the alterations of the NoL index and the standard monitoring (M...
Detailed Description
The purpose of this prospective pragmatic study is to evaluate the changes in NoL index, Heart Rate (HR) and Mean Arterial Blood Pressure (MABP) following the painful stimulus that represents laryngos...
Eligibility Criteria
Inclusion
- ASA status I or II
- Mallampati class I or II
- Patients \> 18 years old
- Elective general, gynecological, neurological, orthopedic, plastic or urological surgery under general anesthesia
- Type of surgery that usually necessitate endotracheal intubation and controlled ventilation
- Non-inlusion Criteria:
- Patient refusal
- History of psychiatric diseases or psychological problems (including mental retardation); inability to give consent; language barrier.
- Anticipated difficult airway (Mallampati class III and IV, thyromental distance \< 6 cm, mouth opening \< 3 cm, neck extension \<80° and neck flexion \<35°, inability to prognath, meaning bringing lower mandibular before the upper maxilla)
- Patient with history of neck rigidity or instability
- BMI \> 30
- Patient with beard (because of recognized risk for difficult ventilation)
- Patient with history of oropharyngeal or tracheal surgery (excluding adenoidectomy, amygdalectomy and teeth removal)
- Severe coronary artery disease
- Serious cardiac arrhythmias (including atrial fibrillation)
- Use of β-blockers (all types)
- History of opioid or illicit drug substance abuse
- Chronic use of psychotropic and/or opioid drugs
- Allergy to remifentanil or propofol
- Pregnancy
- Contraindications to mask ventilation (GI tract obstruction, pregnancy, active GERD, non-fasting patients)
- Difficult mask ventilation (before randomization at the first laryngoscopy)
Exclusion
- Unexpected difficult airway requesting excessive, possibly painful airway manipulations
- Requiring hemodynamic support with vasopressors or inotropes 5 minutes before first laryngoscopy to 3 minutes after insertion of ETT
Key Trial Info
Start Date :
September 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 2 2021
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT03277872
Start Date
September 5 2017
End Date
July 2 2021
Last Update
October 4 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hopital Maisonneuve Rosemont, CIUSSS de l'Est de l'Ile de Montreal
Montreal East, Quebec, Canada, H1T2M4